IGC Pharma (IGC) Earnings Date, Estimates & Call Transcripts $0.33 0.00 (-0.03%) Closing price 05/21/2025 03:58 PM EasternExtended Trading$0.33 +0.01 (+2.45%) As of 07:45 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesOwnershipSEC FilingsBuy This Stock IGC Pharma Earnings Summary IGC Pharma posted Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.02, which topped analysts' consensus estimates of -$0.03 by $0.01. Quarterly revenue was reported to be $0.41 million, above analyst estimates of $0.29 million. With a trailing EPS of -$0.11, IGC Pharma's earnings are expected to decrease next year, from ($0.11) to ($0.12) per share. Nov. 12 Earnings ResourcesNov. 12 Earnings ReportLatest Earnings DateNov. 12EstimatedConsensus EPS (Nov. 12) -$0.03 Actual EPS (Nov. 12) -$0.02 Beat By $0.01 Actual Revenue (Nov. 12) $0.41M Get IGC Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IGC Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up IGC Pharma Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($0.11) EPSNext Year EPS Consensus Estimate ($0.12) EPS IGC Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/12/2024--$0.03-$0.02+$0.01-$0.02$0.29M$0.41M IGC Pharma Earnings - Frequently Asked Questions When did IGC Pharma announce their last quarterly earnings? IGC Pharma (NYSEMKT:IGC) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on IGC's earnings history. Did IGC Pharma beat their earnings estimates last quarter? In the previous quarter, IGC Pharma (NYSEMKT:IGC) reported ($0.02) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.03) by $0.01. Learn more on analysts' earnings estimate vs. IGC's actual earnings. How much revenue does IGC Pharma generate each year? IGC Pharma (NYSEMKT:IGC) has a recorded annual revenue of $1.24 million. How much profit does IGC Pharma generate each year? IGC Pharma (NYSEMKT:IGC) has a recorded net income of -$13 million. IGC has generated -$0.11 earnings per share over the last four quarters. What is IGC Pharma's EPS forecast for next year? IGC Pharma's earnings are expected to decrease from ($0.11) per share to ($0.12) per share in the next year. More Earnings Resources from MarketBeat Related Companies HilleVax Earnings Results Cardiol Therapeutics Earnings Results Immunic Earnings Results Lexeo Therapeutics Earnings Results Zentalis Pharmaceuticals Earnings Results Oramed Pharmaceuticals Earnings Results Virios Therapeutics Earnings Results Instil Bio Earnings Results Galectin Therapeutics Earnings Results Vaxart Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NYSEMKT:IGC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredHow I profit during chaos…This Guy THRIVES on Chaos Wall Street legend Larry Benedict has thrived through every major market crash. I...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IGC Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IGC Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.